157 related articles for article (PubMed ID: 28939823)
1. Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer.
Mitra S; Montgomery JE; Kolar MJ; Li G; Jeong KJ; Peng B; Verdine GL; Mills GB; Moellering RE
Nat Commun; 2017 Sep; 8(1):660. PubMed ID: 28939823
[TBL] [Abstract][Full Text] [Related]
2. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
Mitra S; Federico L; Zhao W; Dennison J; Sarkar TR; Zhang F; Takiar V; Cheng KW; Mani S; Lee JS; Mills GB
Oncotarget; 2016 Jun; 7(26):40252-40265. PubMed ID: 27259233
[TBL] [Abstract][Full Text] [Related]
3. RAB25 confers resistance to chemotherapy by altering mitochondrial apoptosis signaling in ovarian cancer cells.
Temel SG; Giray A; Karakas B; Gul O; Kozanoglu I; Celik H; Basaga H; Acikbas U; Sucularli C; Oztop S; Aka Y; Kutuk O
Apoptosis; 2020 Dec; 25(11-12):799-816. PubMed ID: 32901335
[TBL] [Abstract][Full Text] [Related]
4. Rab25 and RCP in cancer progression.
Cho KH; Lee HY
Arch Pharm Res; 2019 Feb; 42(2):101-112. PubMed ID: 30761451
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells.
Liu Y; Tao X; Jia L; Cheng KW; Lu Y; Yu Y; Feng Y
Mol Med Rep; 2012 Nov; 6(5):1006-12. PubMed ID: 22940905
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional analysis of FIP2 binding to the endosome-localised Rab25 GTPase.
Lall P; Horgan CP; Oda S; Franklin E; Sultana A; Hanscom SR; McCaffrey MW; Khan AR
Biochim Biophys Acta; 2013 Dec; 1834(12):2679-90. PubMed ID: 24056041
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y; Xin XY; Chen BL; Ma X
Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
[TBL] [Abstract][Full Text] [Related]
8. Rab25 in cancer: a brief update.
Mitra S; Cheng KW; Mills GB
Biochem Soc Trans; 2012 Dec; 40(6):1404-8. PubMed ID: 23176489
[TBL] [Abstract][Full Text] [Related]
9. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY
Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J
Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor function of Rab25 in triple-negative breast cancer.
Cheng JM; Volk L; Janaki DK; Vyakaranam S; Ran S; Rao KA
Int J Cancer; 2010 Jun; 126(12):2799-812. PubMed ID: 19795443
[TBL] [Abstract][Full Text] [Related]
12. Is Rab25 a tumor promoter or suppressor--context dependency on RCP status?
Tang BL
Tumour Biol; 2010 Aug; 31(4):359-61. PubMed ID: 20376596
[TBL] [Abstract][Full Text] [Related]
13. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB
Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842
[TBL] [Abstract][Full Text] [Related]
14. Loss of RAB25 expression in breast cancer.
Cheng JM; Ding M; Aribi A; Shah P; Rao K
Int J Cancer; 2006 Jun; 118(12):2957-64. PubMed ID: 16395697
[TBL] [Abstract][Full Text] [Related]
15. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
16. Rab25 upregulation correlates with the proliferation, migration, and invasion of renal cell carcinoma.
Li Y; Jia Q; Zhang Q; Wan Y
Biochem Biophys Res Commun; 2015 Mar; 458(4):745-50. PubMed ID: 25686498
[TBL] [Abstract][Full Text] [Related]
17. Direct targeting of Rab-GTPase-effector interactions.
Spiegel J; Cromm PM; Itzen A; Goody RS; Grossmann TN; Waldmann H
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2498-503. PubMed ID: 24481744
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Staining for Ras-Related Protein 25 (RAB25) Associates with Luminal B Breast Cancer Subtype.
Belhadj A; Addou-Klouche L; Bouakline I; Medjamia M; Benammar HJ; Sahraoui T
Gulf J Oncolog; 2020 Jan; 1(32):26-33. PubMed ID: 32342915
[TBL] [Abstract][Full Text] [Related]
19. The action of small GTPases Rab11 and Rab25 in vesicle trafficking during cell migration.
Kessler D; Gruen GC; Heider D; Morgner J; Reis H; Schmid KW; Jendrossek V
Cell Physiol Biochem; 2012; 29(5-6):647-56. PubMed ID: 22613965
[TBL] [Abstract][Full Text] [Related]
20. Rab25 is responsible for phosphoinositide 3-kinase/AKT‑mediated cisplatin resistance in human epithelial ovarian cancer cells.
Fan Y; Wang L; Han X; Liu X; Ma H
Mol Med Rep; 2015 Mar; 11(3):2173-8. PubMed ID: 25405658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
